These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1246006)

  • 21. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring naloxone antagonism of discriminative opioid stimulus.
    Krimmer EC; Barry H
    Fed Proc; 1982 May; 41(7):2319-22. PubMed ID: 7042395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
    Medvedev IO; Dravolina OA; Bespalov AY
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids.
    Young AM; Masaki MA; Geula C
    J Pharmacol Exp Ther; 1992 Apr; 261(1):246-57. PubMed ID: 1560372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of behavioral effects of morphine, meperidine and normeperidine by naloxone and by morphine tolerance.
    Witkin JM; Leander JD; Dykstra LA
    J Pharmacol Exp Ther; 1983 May; 225(2):275-83. PubMed ID: 6842391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimuli produced by clonidine in spontaneously hypertensive rats: generalization to antihypertensive drugs with different mechanisms of action.
    Lal H; Yaden S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):33-9. PubMed ID: 3965699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats.
    Shannon HE
    J Pharmacol Exp Ther; 1982 Jul; 222(1):146-51. PubMed ID: 7086696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.
    Oliveto AH; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):8-18. PubMed ID: 1850479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinforcement frequency, but not gender, determines sensitivity to discriminative stimulus effects of morphine.
    Craft RM; Morgan CL; Bernal SA
    Behav Pharmacol; 1998 Jul; 9(4):357-62. PubMed ID: 10065924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.
    Jackson A; Tattersall D; Bentley G; Rycroft W; Bourson A; Hargreaves R; Tricklebank M; Iversen S
    Neuropeptides; 1994 May; 26(5):343-53. PubMed ID: 8065550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1981 Mar; 216(3):500-9. PubMed ID: 7205630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
    McMillan DE; Sun WL; Hardwick WC
    J Pharmacol Exp Ther; 1996 Jul; 278(1):50-61. PubMed ID: 8764335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative stimulus effects of pentobarbital in rats.
    Takada K
    Yakubutsu Seishin Kodo; 1982 Jul; 2(1):47-55. PubMed ID: 7187794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat.
    Holtzman SG
    Psychopharmacologia; 1976 Apr; 46(3):223-7. PubMed ID: 951457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.